April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
April 18, 2024 EU Moves Toward Single Capital Market Union
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
Wall Street Lunch: Big Tech Bearishness?
Apple Should Climb The Wall Of Worry
Microsoft Q3 Preview: Focusing On Copilot
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Oramed Pharmaceuticals (ORMP) stock forecast for 2025
Updated: April 23, 2024 (11:17)
Sector: HealthcareThe share price of Oramed Pharmaceuticals Inc. (ORMP) now
50/200 Day Moving Average: $2.898 / $2.675
This figure corresponds to the Average Price over the previous 50/200 days. For Oramed Pharmaceuticals stocks, the 50-day moving average is the resistance level today.
For Oramed Pharmaceuticals stocks, the 200-day moving average is the resistance level today.
Are you interested in Oramed Pharmaceuticals Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Oramed Pharmaceuticals stock price in 2025. How much will one Oramed Pharmaceuticals share be worth in 2025? Is it worth taking profit / loss on ORMP stock now or waiting? What are analysts' forecasts for Oramed Pharmaceuticals stock?
We forecast Oramed Pharmaceuticals stock performance using neural networks based on historical data on ORMP stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Oramed Pharmaceuticals Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Oramed Pharmaceuticals analysts is $4.25. Today 200 Day Moving Average is the support level (2.675 $). 50 Day Moving Average is the resistance level (2.898 $).
Historical and forecast chart of Oramed Pharmaceuticals Inc. stock
The chart below shows the historical price of Oramed Pharmaceuticals stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ORMP stock price can be found in the table below.
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.
Oramed Pharmaceuticals (ORMP) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.14 | 1.88 | 2.36 | 20.25 % |
| Feb | 2.08 | 1.94 | 2.25 | 13.98 % |
| Mar | 1.84 | 1.76 | 1.96 | 10.30 % |
| Apr | 1.59 | 1.44 | 1.74 | 17.43 % |
| May | 1.83 | 1.73 | 2.01 | 13.92 % |
| Jun | 2.06 | 1.94 | 2.14 | 9.23 % |
| Jul | 2.21 | 2.02 | 2.28 | 11.62 % |
| Aug | 2.33 | 2.21 | 2.57 | 13.96 % |
| Sep | 2.60 | 2.49 | 2.90 | 13.89 % |
| Oct | 2.72 | 2.45 | 2.82 | 13.03 % |
| Nov | 2.65 | 2.35 | 2.97 | 20.79 % |
| Dec | 2.39 | 2.14 | 2.54 | 15.78 % |
Oramed Pharmaceuticals information and performance
HI-TECH PARK 2/4 GIVAT-RAM, PO BOX 39098, JERUSALEM, IL
Market capitalization of the Oramed Pharmaceuticals Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ORMP shares in the company outstanding by the market price of one share.
EBITDA of Oramed Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Oramed Pharmaceuticals price target for 2025 by month
Target values for the price of one Oramed Pharmaceuticals share for Jan 2025.
In Jan, the Positive dynamics for Oramed Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 20.254% volatility is expected.
Pessimistic target level: 1.88
Optimistic target level: 2.36
Target values for the price of one Oramed Pharmaceuticals share for Feb 2025.
In Feb, the Negative dynamics for Oramed Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 13.976% volatility is expected.
Pessimistic target level: 1.94
Optimistic target level: 2.25
Target values for the price of one Oramed Pharmaceuticals share for Mar 2025.
In Mar, the Negative dynamics for Oramed Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 10.301% volatility is expected.
Pessimistic target level: 1.76
Optimistic target level: 1.96
Target values for the price of one Oramed Pharmaceuticals share for Apr 2025.
In Apr, the Negative dynamics for Oramed Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 17.429% volatility is expected.
Pessimistic target level: 1.44
Optimistic target level: 1.74
Target values for the price of one Oramed Pharmaceuticals share for May 2025.
In May, the Positive dynamics for Oramed Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 13.922% volatility is expected.
Pessimistic target level: 1.73
Optimistic target level: 2.01
Target values for the price of one Oramed Pharmaceuticals share for Jun 2025.
In Jun, the Positive dynamics for Oramed Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 9.226% volatility is expected.
Pessimistic target level: 1.94
Optimistic target level: 2.14
Target values for the price of one Oramed Pharmaceuticals share for Jul 2025.
In Jul, the Positive dynamics for Oramed Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 11.617% volatility is expected.
Pessimistic target level: 2.02
Optimistic target level: 2.28
Target values for the price of one Oramed Pharmaceuticals share for Aug 2025.
In Aug, the Positive dynamics for Oramed Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 13.963% volatility is expected.
Pessimistic target level: 2.21
Optimistic target level: 2.57
Target values for the price of one Oramed Pharmaceuticals share for Sep 2025.
In Sep, the Positive dynamics for Oramed Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 13.888% volatility is expected.
Pessimistic target level: 2.49
Optimistic target level: 2.90
Target values for the price of one Oramed Pharmaceuticals share for Oct 2025.
In Oct, the Positive dynamics for Oramed Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 13.031% volatility is expected.
Pessimistic target level: 2.45
Optimistic target level: 2.82
Target values for the price of one Oramed Pharmaceuticals share for Nov 2025.
In Nov, the Negative dynamics for Oramed Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 20.787% volatility is expected.
Pessimistic target level: 2.35
Optimistic target level: 2.97
Target values for the price of one Oramed Pharmaceuticals share for Dec 2025.
In Dec, the Negative dynamics for Oramed Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 15.782% volatility is expected.
Pessimistic target level: 2.14
Optimistic target level: 2.54
